{
  "docId": "019dd923-622c-750b-8b9a-101b5bfde4b8",
  "docSlug": "a70fecd99534",
  "documentTitle": "Berkeley Lights (BLI)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-09-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 46,
  "pageCount": 158,
  "prevPage": 45,
  "nextPage": 47,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a direct expert quote to validate the thesis that cost is a primary barrier to sales.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-101b5bfde4b8/46",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8#slide-46",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The overall cost is high, and I think that's the hesitation as well as the budget.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-2041-7259-a876-e91c085586f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "paragraph",
      "text": "Amgen employee #1 (cont’d): BLI upfront cost of $2MM makes it challenging to get approved; ongoing operating costs of consumables and FTE’s turn off users. We note that Amgen has a $130B market cap and has one of the largest budgets on earth – if they are complaining, we wonder what chance that leaves BLI with small and mid-tier biotech’s, much less academic institutions who typically presage and lead discovery, publications, and commercial adoption.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8054ad6b-f5cf-4d10-9686-9c147e42160c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.86,
        "x": 0.07,
        "y": 0.39
      },
      "kind": "quote",
      "text": "Amgen, even with its essentially infinite budget as one of the largest biotech’s, complains about the upfront and ongoing cost of BLI’s instrument. One instrument is $2-million. That’s very, very challenging to get approved. I think that’s one of the main reasons [they’ve sold so few machines], as well as the cost of running the experiments, which is not cheap. Let’s say one instrument has four chip holders. One chip for one process is between $1500 to $1750. So, one chip, one run. And then you have the critical reagents; they are between $200 to $500 depending on which process you are running. And then, of course, the FTEs and then all the other areas. The overall cost is high, and I think that’s the hesitation as well as the budget.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87b48017-5495-468f-a4e8-cca7227caacf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "One instrument is $2-million. That’s very, very challenging to get approved. I think that’s one of the main reasons [they’ve sold so few machines], as well as the cost of running the experiments, which is not cheap. Let’s say one instrument has four chip holders. One chip for one process is between $1500 to $1750. So, one chip, one run. And then you have the critical reagents; they are between $200 to $500 depending on which process you are running. And then, of course, the FTEs and then all the other areas. The overall cost is high, and I think that’s the hesitation as well as the budget. — Amgen employee #1",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-2041-7259-a876-edd70cd46c6c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.05,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cf8b348-3931-4847-bf6e-9fb4c96c6274",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "2A) Amgen employee #1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5141b5cd-3104-4ff7-afd2-7298b3b71187",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Villain slide",
      "slug": "villain-slide",
      "agent": null,
      "layer": "slide",
      "matchId": "8c25ea44-ddfc-404d-a33d-d8401ec75d36",
      "evidence": "The slide presents a critical view of BLI instruments, highlighting their high costs and the challenges they pose for adoption, even by well-capitalized firms like Amgen.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "7a503ec7-72e4-46a4-84fb-bfd330abbc7a",
      "evidence": "The slide frames the high cost of the product as the 'villain' preventing adoption.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 75,
      "from": 17,
      "beatId": "dbc4e03f-819a-4342-92d6-d159c538f28f",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Exposure of Contradictions",
      "beatSlug": null,
      "evidence": "The document exposes contradictions in Berkeley Lights' claims and actions, highlighting the company's struggles and poor market traction.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 150,
      "from": 42,
      "beatId": "172d6e2f-be3f-4802-92e5-e7e412ccdabe",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Testimonials from Customers and Former Employees",
      "beatSlug": null,
      "evidence": "The document presents testimonials from customers and former employees, providing first-hand accounts of the challenges and limitations of Berkeley Lights' product.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}